Literature DB >> 19626343

Membranous lupus nephritis in Chinese children--a case series and review of the literature.

Sik-Nin Wong1, Winnie Kwai-Yu Chan, Joannie Hui, Stella Chim, Tsz-Leung Lee, Kwok-Piu Lee, Lettie Chuk-Kwan Leung, Niko Kei-Chiu Tse, So-Fun Yuen.   

Abstract

We retrospectively reviewed the cases of 13 lupus nephritis children with pure membranous glomerulonephritis (MGN; Group A) and ten children with mixed proliferative and membranous nephritis (Group B). The children were identified through a territory-wide survey of patients between 1990 and 2003. All were ethnic Chinese. Age at diagnosis ranged from 3.7 to 18.6 years (Group A) and from 9.6 to 22.1 years (Group B). Female-to-male ratios were 12:1 (Group A) and 9:1 (Group B). Group A patients were more often nephrotic than Group B patients (11/13 vs. 5/10, p = 0.17). The glomerular filtration rate (GFR) at presentation was normal in all but two patients (one from each group). For induction, Group B patients consistently received prednisolone and cyclophosphamide; in contrast, the cytotoxic regimens in Group A patients varied from cyclophosphamide (five patients), mycophenolate mofetil (two patients), azathiorpine plus cyclosporine (one patient), and azathioprine alone (one patient). After a median follow-up of 7.6-7.8 years, one Group A patient had died of fulminant lupus. One survivor in Group B had a GFR < 90 ml/min per 1.73 m(2). Proteinuria persisted in five Group A patients and two Group B patients. In conclusion, Group B patients had good prognosis in terms of survival and proteinuria control. The only death occurred in Group A, and five of the 12 survivors in this group had persistent proteinuria. Further studies are needed to define the best treatment for pure lupus MGN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626343     DOI: 10.1007/s00467-009-1257-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Prognosis of lupus membranous nephritis in children.

Authors:  K K Lau; D P Jones; B H Ault
Journal:  Lupus       Date:  2007       Impact factor: 2.911

2.  Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children.

Authors:  Abdullah A Al Salloum
Journal:  Pediatr Nephrol       Date:  2003-03-28       Impact factor: 3.714

3.  Treatment of membranous lupus nephritis.

Authors:  G Moroni; M Maccario; G Banfi; S Quaglini; C Ponticelli
Journal:  Am J Kidney Dis       Date:  1998-04       Impact factor: 8.860

Review 4.  Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature.

Authors:  D Hallegua; D J Wallace; A L Metzger; R Z Rinaldi; J R Klinenberg
Journal:  Lupus       Date:  2000       Impact factor: 2.911

5.  Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Authors:  Radovan Bogdanović; Vesna Nikolić; Srdjan Pasić; Jovan Dimitrijević; Jasmina Lipkovska-Marković; Jelena Erić-Marinković; Milos Ognjanović; Aleksandra Minić; Natasa Stajić
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

6.  Clinical presentation and outcome in a cohort of paediatric patients with membranous lupus nephritis.

Authors:  Carl H Cramer; Michelle Mills; Rudolph P Valentini; William E Smoyer; Hillary Haftel; Patrick D Brophy
Journal:  Nephrol Dial Transplant       Date:  2007-07-29       Impact factor: 5.992

7.  Lupus nephritis: prognostic factors in children.

Authors:  D K McCurdy; T J Lehman; B Bernstein; V Hanson; K K King; R Nadorra; B H Landing
Journal:  Pediatrics       Date:  1992-02       Impact factor: 7.124

Review 8.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

9.  Lupus nephritis in children: a longitudinal study of prognostic factors and therapy.

Authors:  N Baqi; S Moazami; A Singh; H Ahmad; S Balachandra; A Tejani
Journal:  J Am Soc Nephrol       Date:  1996-06       Impact factor: 10.121

10.  Clinicopathological study of the WHO classification in childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciaran Duffy; Chantal Bernard; Rosie Scuccimarri; Karen Watanabe Duffy; Rhoda Kagan; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2004-03-12       Impact factor: 3.714

View more
  6 in total

1.  Clinical presentation and outcomes of childhood-onset membranous lupus nephritis.

Authors:  Maria Pereira; Eyal Muscal; Karen Eldin; M John Hicks; Anna Carmela P Sagcal-Gironella; Marietta DeGuzman; Scott E Wenderfer
Journal:  Pediatr Nephrol       Date:  2017-07-17       Impact factor: 3.714

Review 2.  Paediatric use of mycophenolate mofetil.

Authors:  Heather J Downing; Munir Pirmohamed; Michael W Beresford; Rosalind L Smyth
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

Review 3.  Management and outcomes in children with lupus nephritis in the developing countries.

Authors:  Priyanka Khandelwal; Srinivasavaradan Govindarajan; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2022-10-18       Impact factor: 3.651

4.  Presentation and outcome of paediatric membranous non-proliferative lupus nephritis.

Authors:  Boris Hugle; Earl D Silverman; Pascal N Tyrrell; Elizabeth A Harvey; Diane Hébert; Susanne M Benseler
Journal:  Pediatr Nephrol       Date:  2014-07-31       Impact factor: 3.714

5.  Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.

Authors:  A Boneparth; S E Wenderfer; L Nandini Moorthy; S M Radhakrishna; A C P Sagcal-Gironella; E von Scheven
Journal:  Lupus       Date:  2016-08-20       Impact factor: 2.911

Review 6.  Membranous nephropathy: not just a disease for adults.

Authors:  Rivka Ayalon; Laurence H Beck
Journal:  Pediatr Nephrol       Date:  2013-12-29       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.